Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Motif Bio Plc LSE:MTFB London Ordinary Share GB00BVVT4H71 ORD 0.01P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 0.50 0.40 0.55 - 0.00 00:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 3.2 -1.5 - 3

Motif Bio Share Discussion Threads

Showing 8901 to 8921 of 9100 messages
Chat Pages: 364  363  362  361  360  359  358  357  356  355  354  353  Older
DateSubjectAuthorDiscuss
07/1/2021
18:56
Absolutely Chuffer - let’s not forget Lumsden had all bases covered at around 8p and many were in at 35p plus This shower had better deliver a rainbow or surely their reputations can’t survive this amateur hour as well
scottdavid70
07/1/2021
13:13
Greedy Gold and Graham only need to do a RTO to get their money. Lumsden an incredible BONUS of $100,000 and Gold $325,000 in deferred salary. If shareholders get sweet nothing they still get their money. Given there was zero Corporate Governance which continues with no communication from Motif then we can assume they will happily shaft investors who paid their lavish lifestyles. I would be hammering at their door asking for how a prospectus and vote can happen if investors are only getting an Update second half of the month. Smells v bad
scottdavid70
07/1/2021
11:19
It says he raised $125 million but what is doesn’t say is what he took as a CEO in percentage terms as a salary due to that fundraising. So the investors in his new come need to know that the more he raises the more tilted his salary is which means dilution which is bad for shareholders was good for Graham Lumsden at Motif. They have been warned
scottdavid70
07/1/2021
11:17
I give up - unreal that after the absolute carnage investors have had to deal with her Graham Lumsden gets a new job hxxps://www.linkedin.com/posts/biomarck-pharmaceuticals-ltd%2E_clinicaltrials-ards-pharmaceuticals-activity-6752635711410757632-oWLT
scottdavid70
06/1/2021
17:30
So less than 14 days we need to see a prospectus and have a vote via a General Meeting after the 15th January- I was terrible at maths but that seems impossible to me - anyone else got an explanation? Motif and Walbrook won’t explain - that’s not a good sign
scottdavid70
06/1/2021
16:19
Wow a whole day w/o a post from Scottdavid
georgia103
05/1/2021
17:15
Absolutely correct,just hot air and an RNS that says nothing. There is no deal nor will there be, its all smoke and mirrors ment to give hope where none exists. Another in a long list of BOD failures including Flybe, Thomas cook, Debenhams and many more. If you have lost money here I sure hope that you all have made it back elsewhere.
perfectstorm
05/1/2021
16:39
Good Corporate Governance doesn’t look like this
scottdavid70
05/1/2021
16:38
Robblertwo just starting to understand how the timings are seriously a concern to current shareholders on LSE Answers are needed IMMEDIATELY from the Company as to the timings considering today’s RNS stating an update SECOND HALF OF JANUARY
scottdavid70
05/1/2021
16:36
I have got my friends to ask Walbrook and Motif about a General Meeting given it needs a minimum of 14 days in advance of the 28th January. Nothing back. Pretty simple question and no replies to anyone. They have asked about the prospectus and vote they have told us numerous times. Nothing back. This BOd continues to NOT have correct CORPORATE GOVERNANCE and so far has NOT PROVED ITS WORKING IN SHAREHOLDERS BEST INTERESTS. Answers are needed from the Company
scottdavid70
05/1/2021
08:49
How do we get to vote on the deal and see the prospectus if they only update us with less than 14 days to go to call a General Meeting????? Wow!! Ask the question
scottdavid70
05/1/2021
08:42
Not a lot, but the target company could have loads, otherwise a fundraise against the new listed company shares ( consolidation ) going forward.Gl ;-) ps they've got around £500k cash to provide funds for the RTO.
moneymunch
05/1/2021
08:41
Yep, looks like a hot air announcement, next one will likely be "no deal could be struck" and off they trot.
jibba jabber
05/1/2021
08:36
Why haven’t Walbrook PR tweeted this RNs news like they do every other company if this is such big news? Feels like they know something about how current shareholders will be treated is my guess and they want as little involvement as possible
scottdavid70
05/1/2021
08:32
Let’s see just how much these Directors look after shareholders best interests as they are supposed too with regard any potential dilution. I expect it to be grotesque and the shareholders who followed the Leader Lumsden to pay a heavy price if there even is a RTO
scottdavid70
05/1/2021
07:40
They got cash for RTO?
richardjohn10
05/1/2021
07:28
Covid or not....this is transformational news...Gl ;-)
moneymunch
05/1/2021
07:19
well if they come out with someting in the Covid arena well.....
dafad
05/1/2021
07:17
All good things.....ho ho ho ho .....Gla ;-)
moneymunch
03/1/2021
10:20
Where is this Covid Therapeutic that Motif said several companies wanted to launch? Anyone seen the Birmingham caee rates? Birmingham's case rate is up 42% in 7 days Cases rate now the highest on record - huge 3rd Wave underway Strange that this therapeutic isn’t been rushed a bit harder out isn’t given the sad scenario out on the streets and in the hospital? Something doesn’t make sense does it?
scottdavid70
03/1/2021
09:06
For those that are interested here is the PDF of the new patents for Iclaprim with Sandoz hxxps://patentimages.storage.googleapis.com/c8/49/32/c337043ea6d147/WO2020161284A1.pdf Clear work has been done on it this year especially around 3rd March 2020 (when Motif Bioscience still owned Iclaprim) when you read to the end but we are still mushrooms sadly despite allowing the Board a life of luxury while they failed to get Iclaprim approved and took grotesque salaries.
scottdavid70
Chat Pages: 364  363  362  361  360  359  358  357  356  355  354  353  Older
ADVFN Advertorial
Your Recent History
LSE
MTFB
Motif Bio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210225 11:18:51